First Tissue-Agnostic Drug Approval Issued

被引：28
|
作者：
Poh, Alissa
机构：
来源：
CANCER DISCOVERY | 2017年 / 7卷 / 07期
关键词：
D O I：
10.1158/2159-8290.CD-NB2017-078
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The PD-1 inhibitor pembrolizumab received accelerated approval for adult and pediatric patients with solid tumors that are mismatch repair-deficient or microsatellite instability-high. This is the first time the FDA has greenlighted a drug based not on tumor type, but on a common biomarker. ©2017 American Association for Cancer Research.
引用
收藏
页码：656 / 656
页数：1
相关论文
共 50 条
  • [21] FDA Approvals of Oncology Drugs for Tissue-Agnostic Indications
    Zettler, Marjorie E. E.
    TARGETED ONCOLOGY, 2023, 18 (05) : 777 - 792
  • [22] Controversy of tissue-agnostic approvals in immunotherapy and targeted therapy
    Bose, Chinmoy K.
    MEDICAL ONCOLOGY, 2022, 39 (05)
  • [23] Controversy of tissue-agnostic approvals in immunotherapy and targeted therapy
    Chinmoy K. Bose
    Medical Oncology, 39
  • [24] The evolving landscape of tissue-agnostic therapies in precision oncology
    Subbiah, Vivek
    Gouda, Mohamed A.
    Ryll, Bettina
    Burris, Howard A.
    Kurzrock, Razelle
    CA-A CANCER JOURNAL FOR CLINICIANS, 2024, 74 (05) : 433 - 452
  • [25] Impact of tissue-agnostic approvals for patients with gastrointestinal malignancies
    Bhamidipati, Deepak
    Subbiah, Vivek
    TRENDS IN CANCER, 2023, 9 (03) : 237 - 249
  • [26] FDA Approvals of Oncology Drugs for Tissue-Agnostic Indications
    Marjorie E. Zettler
    Targeted Oncology, 2023, 18 : 777 - 792
  • [27] In a major shift, cancer drugs go 'tissue-agnostic'
    Garber, Ken
    SCIENCE, 2017, 356 (6343) : 1111 - 1112
  • [28] The significance of tissue-agnostic biomarkers in solid tumors: the more the merrier?
    Gristina, Valerio
    Pisapia, Pasquale
    Barraco, Nadia
    Pepe, Francesco
    Iacono, Federica
    La Mantia, Maria
    Peri, Marta
    Galvano, Antonio
    Incorvaia, Lorena
    Badalamenti, Giuseppe
    Bazan, Viviana
    Troncone, Giancarlo
    Russo, Antonio
    Malapelle, Umberto
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2023, 23 (10) : 851 - 861
  • [29] Review and Prospect of Tissue-agnostic Targeted Strategies in Anticancer Therapies
    Peng, Yu
    Tao, Hongxun
    Gao, Yuanqing
    Yang, Yuanyuan
    Chen, Zhiyong
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2021, 21 (05) : 404 - 425
  • [30] Tissue-resident regulatory T cells as tissue-agnostic immunomodulatory populations
    Bapat, Sagar P.
    Gardner, James M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2024, 24 (11) : 1922 - 1923
12345